Skip to content

Elevated insulin associated with buffalo hump in Australian study

Tenofovir / FTC 'non-inferior' to Combivir after one year, Gilead study shows (corrected)

Cotrimoxazole prophylaxis reduces the risk of death in TB patients

Risk of resistance with nevirapine-containing HAART after pregnancy, even when stopped correctly

Lowest-ever CD4 cell count can predict how long treatment can be interrupted

Boosted saquinavir monotherapy explored as treatment option for patients with advanced HIV in South Africa

HIV conspiracy theories associated with poorer condom attitude and use amongst African American men

Substantial, but imperfect adherence a major risk factor for resistance amongst patients starting HAART

WHO: 3 x 5 still on target, 700,000 now on treatment but $2 billion more needed in 2005